Products and services

      Products and services

      Youngsure ?Orlistat Capsules

      For the treatment of obese or overweight patients (body mass index≥24)

      Youngsure ?Orlistat Capsules

      For the treatment of obese or overweight patients (body mass index≥24)

      Donepezil Hydrochloride Tablets

      Indication: For the treatment of minor, moderate or severe symptoms of Alzheimer’s disease.

      Ropinirole Hydrochloride Tablets

      Indication: This product is suitable to treat the symptoms and signs of Primary Parkinson’s disease in combination with levodopa.

      Suplatast Tosilate Granules

      Indication: This product is suitable for the treatment of bronchial asthma

      Geruishu? Metformin Hydrochloride Sustained-release Tablets

      Indication: This product is recommended as a stand-alone treatment in combination with diet and exercise therapy to achieve glycemic control in type 2 diabetes. It can be used in combination with sulfonylureas and insulin to control blood glucose in adults.

      Lingsu? Quetiapine Fumarate Sustained-Release Tablets

      Indication: This product is used for the treatment of depressive episodes in schizophrenia and bipolar disorder.

      Ali? Orlistat Capsules

      Superiormechanism:lipaseinhibitor,inhibitsfatabsorptioninthediet.Highsafety:non-centralnervousactionweightreductiondrug,noeffectofappetitesuppression;minimallyabsorptionintothebloodstream.Significante

      Saige’en ? Tropisetron Hydrochloride Injection

      Indication: Prevent nausea and vomiting caused by cancer chemotherapy; treat nausea and vomiting after surgery.

      Miconazole Nitrate Suppository

      Indication: Topical treatment of dual infections caused by Candida vulvovaginosis and Gram-positive bacteria.

      Youngsure ? Orlistat Capsules

      Indication: For the treatment of obese or overweight patients (body mass index≥24)

      Strength: 120mg

      Package: Aluminum foil for drug package, PVC sheet for packing solid medicine, 3 capsules/blister*1 blister/carton, 18 capsules/blister*1 blister/carton, etc.

      Validity: 36 months

      Approval Number: National Medicine Standard H20123131

      -Superior mechanism: Lipase inhibitor that acts by inhibiting the absorption of dietary fats.

      -Better safety: Non-central nervous action weight reduction drug, no effect of appetite suppression; minimally absorption into the bloodstream.

      -Significant effects: Effectively reduce body fat, significantly reduce waist circumference, and improve related risk factors.

      Purchasing Channels

      Fax:

      微信公眾號

      网上兼职赚钱日结学生软件